<DOC>
	<DOC>NCT00167791</DOC>
	<brief_summary>This is a study of patients who have a high risk of kidney rejection before kidney transplant. The hypothesis is that treatment with a medication called rituximab will make it possible for them to receive a kidney transplant from a donor who previously did not present a good match.</brief_summary>
	<brief_title>Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Active status on a kidney transplant waiting list with positive cross match against a living donor Receipt of a live vaccine within 4 weeks prior to randomization Previous Treatment with Rituximab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>transplant</keyword>
	<keyword>desensitization</keyword>
	<keyword>kidney transplant</keyword>
</DOC>